Global $57.4 Billion Cell And Gene Therapy Manufacturing Market to 2028 – Rising Pressure on Drug Developers/Manufacturers to Meet the Growing Market…

DUBLIN, July 29, 2021 /PRNewswire/ -- The "Cell And Gene Therapy Manufacturing Market Size, Share & Trends Analysis Report by Therapy Type, by Scale (R&D, Commercial), by Mode, by Workflow (Vector Production, Cell Banking), by Region, and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

The global cell and gene therapy manufacturing market size is expected to reach USD 57.4 billion by 2028.

The market is estimated to expand at a CAGR of 20.3% from 2021 to 2028. An exponential rise in clinical pipeline coupled with a rising number of regulatory approvals for advanced therapies has majorly driven the market.

Considering promising growth opportunities in contract development of cellular and gene-modified therapies, market participants are making focused efforts to boost their market presence.

Also, bio manufacturers are signing strategic alliances with contract manufacturers to accelerate the R&D of their candidate programs. Rising demand for CMOs/CDMOs services has led to the entry of several new players as well as expansion of product development capabilities, thereby positively impacting market revenue.

Several novel methods are being introduced to advance cell and gene therapy manufacturing. For instance, the manufacturers are exploring the potential of single-use technology in production workflows.

This technique is gaining increasing attention in this arena to speed the development process while reducing the overall cost and production timeline. Such technological advancements in space are anticipated to bolster market growth in the coming years.

Cell And Gene Therapy Manufacturing Market Report Highlights

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Market Variables, Trends & Scope3.1 Market Segmentation3.2 Parent Market Lineage3.3 Ancillary Market Lineage3.4 Market Dynamics3.4.1 Market Drivers Analysis3.4.1.1 Growing Pipeline Of Cell and Gene Therapy3.4.1.2 Supportive Regulatory Bodies3.4.1.3 Increase In Investment By Government and Private Players3.4.2 Market Restraint Analysis3.4.2.1 Technological Challenges Associated With Manufacturing3.4.2.2 High Cost Of Manufacturing3.4.3 Market Opportunity Analysis3.4.3.1 Rising Pressure On Drug Developers/Manufacturers To Meet The Growing Market Demand3.4.3.2 Expansion In Potential Markets Such As Asia Pacific and Latin America3.4.4 Market Challenge Analysis3.4.4.1 Lack Of Manufacturing Capacity3.5 Swot Analysis; By Factor (Political & Legal, Economic and Technological)3.6 Porter's Five Forces Analysis3.7 Major Deals and Strategic Alliances Analysis3.8 Covid-19 Impact Analysis

Chapter 4 Competitive Analysis4.1 Recent Developments and Impact Analysis By Key Market Participants4.2 Company Mapping, By Location, Purpose, Scale Of Operation, Source Of Cell, Regulatory Compliant4.3 List Of Potential End Users4.4 List Of Emerging Players4.5 Market Differentiators4.6 Competitive Dashboard Analysis4.7 Regional Network Map

Chapter 5 Therapy Type Business Analysis5.1 Cell and Gene Therapy Manufacturing Market: Therapy Type Movement Analysis5.2 Cell Therapy Manufacturing5.2.2 Stem Cell Therapy5.2.3 Non-Stem Cell Therapy5.3 Gene Therapy Manufacturing

Chapter 6 Scale Business Analysis6.1 Cell and Gene Therapy Manufacturing Market: Scale Movement Analysis6.2 Pre-Commercial/R&D Scale Manufacturing6.3 Commercial Scale Manufacturing

Chapter 7 Mode Business Analysis7.1 Cell and Gene Therapy Manufacturing Market: Mode Movement Analysis7.2 Contract Manufacturing7.3 In-House Manufacturing

Chapter 8 Workflow Business Analysis8.1 Cell and Gene Therapy Manufacturing Market: Workflow Movement Analysis8.2 Cell Processing8.3 Cell Banking8.4 Process Development8.5 Fill and Finish Operations8.6 Analytical and Quality Testing8.7 Raw Material Testing8.8 Vector Production

Chapter 9 Regional Business Analysis9.1 Cell and Gene Therapy Manufacturing Market: Regional Movement Analysis

Chapter 10 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/yqyeht

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

Original post:

Global $57.4 Billion Cell And Gene Therapy Manufacturing Market to 2028 - Rising Pressure on Drug Developers/Manufacturers to Meet the Growing Market...